Vaccination targeting a surface sialidase of P. acnes: Implication for new treatment of acne vulgaris

PLoS ONE

Volumn 3, Issue 2, 2008, Pages

  Nakatsuji, Teruaki ^a,b   Liu, Yu Tsueng ^c   Huang, Cheng Po ^b,c   Gallo, Richard L ^a,b   Huang, Chun Ming ^a,b,c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d LA JOLLA INSTITUTE FOR MOLECULAR MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACNE VACCINE; ANTISERUM; BACTERIAL VACCINE; INTERLEUKIN 8; ISOTRETINOIN; MACROPHAGE INFLAMMATORY PROTEIN 2; RECOMBINANT ENZYME; RETINOID; SIALIDASE; BACTERIUM ANTIBODY;

ACNE VULGARIS; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; BACTERIUM ADHERENCE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOTOXICITY; DRUG EFFICACY; DRUG TARGETING; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNIZATION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PROPIONIBACTERIUM ACNES; VACCINATION; ANTIBODY PRODUCTION; BLOOD; CD8+ T LYMPHOCYTE; IMMUNOLOGY; METHODOLOGY; TREATMENT OUTCOME;

MUS; P ACNES; PROPIONIBACTERIUM ACNES;

ACNE VULGARIS; ANTIBODIES, BACTERIAL; ANTIBODY FORMATION; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; NEURAMINIDASE; PROPIONIBACTERIUM ACNES; TREATMENT OUTCOME; VACCINATION;

EID: 45249113958     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0001551     Document Type: Article

References (34)

1. Perry AL, Lambert PA (2006) Propionibacterium acnes. Lett Appl Microbiol 42: 185-188.
2. Layton AM, Dreno B, Gollnick HP, Zouboulis CC (2006) A review of the European Directive for prescribing systemic, isotretinoin for acne vulgaris. J Eur Acad Dermatol Vencreol 20: 773-776.
3. Cooper AJ (1998) Systematic review of Propionibacterium acnes resistance to systemic antibiotics. Med J Aust 169: 259-261.
4. Ochsendorf F (2006) Systemic antibiotic therapy of acne vulgaris. J Dtsch Dermatol Ges 4: 828-841.
5. Gloor M, Wasik B, Becker A, Hoffler U (2002) Inhibition of lipase activity in antibiotic-resistant propionibacterium acnes strains. Dermatology 205: 260-264.
6. Bruggemann H, Henne A, Hoster F, Liesegang H, Wiezer A, et al. (2004) The complete genome sequence of Propionibacterium acnes, a commensal of human skin. Science 305: 671-673.
7. Bruggemann H (2005) Insights in the pathogenic potential of Propionibacterium acnes from its complete genome. Semin Cutan Med Surg 24: 67-72.
8. Johansson BE, Brett IC (2007) Changing perspective on immunization against influenza. Vaccine 25: 3062-3065.
9. Tai SS (2006) Streptococcus pneumoniae protein vaccine candidates: properties, activities and animal studies. Crit Rev Microbiol 32: 139-153.
10. Martin A, Clynes M (1993) Comparison of 5 microplate colorimetric assays for in vitro cytotoxicity testing and cell proliferation assays. Cytotechnology 11: 49-58.
11. Sun B, Ranish JA, Utleg AG, White JT, Yan Y, et al. (2007) Shotgun glycopeptide capture approach coupled with mass spectrometry for comprehensive glycoproteomics. Mol Cell Proteomics 6: 141-149.
12. Wolska Y, Zabielska V, Jakubczak A (2006) Effect of neuraminidase on adherence of Pseudomonas aeruginosa to human buccal epithelial cells. Inhibition of adhesion by monosaccharides. Pol J Microbiol 55: 43-48.
13. Kristian SA, Lauth X, Nizet V, Goetz F, Neumeister B, et al. (2003) Alanylation of teichoic acids protects Staphylococcus aureus against Toll-like receptor 2-dependent host defense in a mouse tissue cage infection model. J Infect Dis 188: 414-423.
14. Zimmerli W, Waldvogel FA, Vaudaux P, Nydegger UE (1982) Pathogenesis of foreign body infection description and characteristics of an animal model. J Infect Dis 146: 487-497.
15. Oeff MK, Seltmann H, Hiroi N, Nastos A, Makrantonaki E, et al. (2006) Differential regulation of Toll-like receptor and CD14 pathways by retinoids and corticosteroids in human sebocytes. Dermatology 213: 266.
16. Abd El All HS, Shoukry NS, El Maged RA, Ayada MM (2007) Immunohistochemical expression of interleukin 8 in skin biopsies from patients with inflammatory acne vulgaris. Diagn Pathol 2: 4.
17. Thiboutot D, Jabara S, McAllister JM, Sivarajah A, Gilliland K, et al. (2003) Human skin is a steroidogenic tissue: steroidogenic enzymes and cofactors are expressed in epidermis, normal sebocytes, and an immortalized sebocyte cell line (SEB- 1). J Invest Dermatol 120: 905-914.
18. Kharat AS, Tomasz A (2003) Inactivation of the artA gene affects localization of surface protein and decreases adhesion of Streptococcus pneumoniae to human pharyngeal cells in vitro. Infect Immun 71: 2758-2765.
19. Tong HH, Li D, Chen S, Long JP, DeMaria TF (2005) Immunization with recombinant Streptococcus pneumoniae neuraminidase NanA protects chinchillas against nasopharyngeal colonization. Infect Immun 73: 7775-7778.
20. Winter C, Schwegmann-Wessels C, Cavanagh D, Neumann U, Herder G (2006) Sialic acid is a receptor determinant for infection of cells by avian Infectious bronchitis virus. J Gen Virol 87: 1209-1216.
21. Basal E, Jain A, Kaushal GP (2OG4) Antibody response to crude cell lysate, of propionibacterium acnes and induction of pro-inflammatory cytokines in patients with acne and normal healthy subjects. J Microbiol 42: 117-125.
22. Dalen A, Hellgren 4 Iversen OJ, Vincent J (1980) Antibodies against extractable components from Propionibacterium acnes in humans with and without acne vulgaris. Arch Dermatol Res 269: 253-259.
23. Zaluga E (1998) [Skin reactions to antigens of propionibacterium acnes in patients with acne vulgaris treated with autovaccine]. Ann Acad Med Stetin 44: 65-85.
24. Marcinkiewicecz J, Bryniarski Y, Nowak B, Dzielska D, Payerhin F (1991) [Immunomodulating properties of Açnevac vaccine]. Med Dosw Mikrobiol 43: 167-174.
25. Loveckova Y, Havlikova I (2002) A microbiological approach to acne vulgaris. Biomed Pap Med Far Univ Palacky Olomouc Czech Repub 146: 29-32.
26. Kobayashi F, Nagoya T, Koshi T, Saino Y (1980) Biphasic protection against bacterial infection in mice induced by vaccination of Propionibacterium acnes. Infect Immun 27: 391-396.
27. Mochizuki H, Nomura T, Kawamura I, Mitsuyama M (2005) Enhanced risistance to Gram-positive bacterium and increased susceptibility to bacterial endotoxin in mice sensitized with Propionibacterium acnes: involvement of Toll-like receptor. FEMS Immunol Med Microbiol 43: 287-293.
28. Romics L Jr, Dolganiuc A, Velayudham A, Kodys K, Mandrekar P, et al. (2005) Toll-like receptor 2 mediates inflammatory cytokine induction but not sensitization for liver injury by Propioni- bacterium acnes. J Leukoc Biol 78: 1255-1264.
29. Taylor G (1996) Sialidases: structures, biological significance and therapeutic potential. Curr Opin Struct Biol 6: 830-837.
30. Webster GF, Ruggieri MR, McGinley KJ (1981) Correlation of Propionibacterium acnes populations with the presence of triglycerides on nonhuman skin. Appl Environ Microbiol 41: 1269-1270.
31. Nakano K, Kiyokane K, Benvenuto-Andrade C, Gonzalez S (2007) Real-timereflectance confocal microscopy, a noninvasive tool for in vivo quantitative evaluation of comedolysis in the rhino mouse model. Skin Pharmacol Physiol 26: 29-36.
32. Takaoki M, Kawaji H (1980) Impaired antibody response against T-dependent antigens in rhino mice. Immunology 40: 27-32.
33. Mirshahpanah P, Maibach HI (2007) Models in acnegenesis. Cutan Ocul Toxicol 26: 195-202.
34. Shi Y, Elmets CA, Smith JW, Liu YT, Chen YR, et al. (2007) Quantitative proteomes and in vivo secretomes of progressive and regressive UV-induced fibrosarcoma tumor cells: Mimicking tumor microenvironment using a dermis-based cell-trapped system linked to tissue chamber. Proteomics 7: 4589-4600.